Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Chronic Lymphatic (Lymphocytic) Leukemia |
Dose: Oral Tablet – 0.1 mg/kg Frequency: once daily Duration: 3 to 6 weeks Note: Reduce initial dose if administered within 4 weeks after a full course of radiation or myelosuppressive therapy or patients with bone marrow disease. Not to exceed 0.1 mg/kg per day if bone marrow infiltrated with lymphocytes. |
|
Indication: Chronic Lymphatic (Lymphocytic) Leukemia |
Dose: Oral Tablet – 0.4 mg/kg (increased by 0.1 mg/kg per dose until response or toxicity observed) Frequency: biweekly Note: Reduce initial dose if administered within 4 weeks after a full course of radiation or myelosuppressive therapy or patients with bone marrow disease. Not to exceed 0.1 mg/kg per day if bone marrow infiltrated with lymphocytes. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Not available – No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment |
Dose: less than 1% (including metabolites) excreted in urine Note: no dose adjustment required |
Administration
- Take on empty stomach
- Take at same time each day
Side Effect
- Neutropenia (25-33%)
- Anemia
- Leukopenia
- Thrombocytopenia
- Seizures
- Hallucinations
- Peripheral neuropathy
- Nausea
- Vomiting
- Pulmonary fibrosis
- GI effects
- Leukemia
- Myelosuppression
- Hyperuricemia
- Infertility
- Hepatotoxicity & jaundice
- Type I hypersensitivity
- Rash
- Stevens-Johnson syndrome (rare)
- Toxic epidermal necrosis (rare)
- Urticaria
- Erythema multiforme (rare)
- Secondary malignancies
- Severe bone marrow suppression
- carcinogenic and human infertility
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Vaccines
|
Impairs immune response; possible infection after admin of live vaccines
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Porphyria
|
Risk of acute attacks
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.